课题基金 / 基金详情

Identification of priming factors that determine cardiac lineage of cardiac stem cells

Identification of priming factors that determine cardiac lineage of cardiac stem cells
确定心脏干细胞心脏谱系的启动因子的鉴定
批准号:
20249046
负责人:
MATSUBARA Hiroaki
金额:
$31.12万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

MATSUBARA Hiroaki的其他基金

相关文献

中文摘要
翻译
越来越多的证据表明,骨形态发生蛋白(BMP)是心脏的诱导,规范和发展的关键。虽然BMP信号通过可溶性BMP结合蛋白紧密调节,但它们在心脏分化过程中如何调节BMP信号仍然未知。为了鉴定在P19细胞的早期心肌细胞分化期间负责BMP信号传导的分子,进行cDNA扣除。我们发现在心肌细胞分化过程中BMP结合蛋白Crossveinless-2(Cv 2)的双峰表达; Cv 2在时间上早于心脏转录因子如Nkx2.5和Tbx 5表达,并在P19细胞中作为BMP信号传导的抑制因子。我们建立了一个P19克隆细胞系,该细胞系含有心脏α-肌球蛋白重链启动子驱动的增强型绿色荧光蛋白基因,以通过流式细胞术监测心脏分化。在分化的前2天期间用BMP 2处理通过下游靶Smadl/5/8蛋白和Idl基因的活化抑制心肌细胞分化,而用Cv 2处理相反地抑制Smadl/5/8活化和Idl表达,导致心脏细胞的产生增加。内源性Cv 2的RNA干扰介导的敲低(KD)显示增加的Smadl/5/8活化和受损的心肌细胞分化。心脏中胚层标志物的表达减少,而Idl和内胚层标志物如Sox 7、Hnf 4和E-钙粘蛋白的表达在Cv 2激酶死细胞中被诱导。通过在分化或与亲本细胞共培养的前2天期间向培养基中添加Cv 2蛋白来拯救这些表型。这些数据表明,Cv 2可能通过在心脏发生的早期阶段抑制BMP信号而指定心脏中胚层谱系。
英文摘要
Increasing evidence indicates that bone morphogenetic proteins (BMPs) are crucial for cardiac induction, specification, and development. Although signaling of BMPs is tightly regulated through soluble BMP-binding proteins, how they regulate BMP signaling during cardiac differentiation remains unknown. To identify molecules responsible for BMP signaling during early cardiomyocyte differentiation of P19 cells, cDNA subtraction was performed. We found a bimodal expression of the BMP-binding protein Crossveinless-2 (Cv2) during cardiomyocyte differentiation ; Cv2 is temporally expressed earlier than cardiac transcription factors such as Nkx2.5 and Tbx5 and acts as a suppressor for BMP signaling in P19 cells. We established a P19 clonal cell line harboring a cardiac alpha-myosin heavy chain promoter-driven enhanced green fluorescent protein gene to monitor cardiac differentiation by flow cytometry. Treatment with BMP2 during the first 2 days of differentiation suppressed cardiomyocyte differentiation through activation of down-stream targets Smadl/5/8 protein and Idl gene, whereas treatment with Cv2 conversely inhibited Smadl/5/8 activation and Idl expression, leading to increased generation of cardiac cells. RNA interference-mediated knockdown (KD) of endogenous Cv2 showed increased Smadl/5/8 activation and impaired cardiomyocyte differentiation. Expression of cardiac mesoderm markers was reduced, whereas expression of Idl and endoderm markers such as Sox7, Hnf4, and E-cadherin was induced in Cv2-kinase dead cells. These phenotypes were rescued by the addition of Cv2 protein to the culture media during the first 2 days of differentiation or co-culture with parental cells. These data suggest that Cv2 may specify cardiac mesodermal lineage through inhibition of BMP signaling at early stage of cardiogenesis.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
心筋由来幹細胞移植による世界初の心筋再生療法 CARDLC PRACTICE
全球首个利用心肌干细胞移植的心肌再生疗法CARDLC PRACTICE
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [谷口法正, 竹原有史, 松原弘明]
通讯作者: 松原弘明
循環器疾患のサイエンス
心血管疾病科学
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [内藤大督, 加藤拓, 片村真紀, 竹原有史, 王英世, 松原弘明]
通讯作者: 松原弘明
Bone marrow AT1 augments neointima formation by promoting mobilization of smooth muscle progenitors via of Smooth Muscle Progenitors via Platelet-Derived SDF-1{alpha}.
骨髓 AT1 通过血小板衍生的 SDF-1{alpha} 促进平滑肌祖细胞的动员,从而增强新内膜形成。
DOI: --
发表时间: 2010
期刊: Arterioscler Thromb Vase Biol
影响因子: --
作者: [Yokoi I, Matsubara H, 他8人、最終著者]
通讯作者: 他8人、最終著者
Long-Term Clinical Outcome of Therapeutic Angiogenesis by Autologous Transplantation of Bone Marrow Mononuclear Cells for Patients With Chronic Limb Ischemia-Results of the TACT Trial, Prognosis, Efficacy and Safety
自体骨髓单核细胞移植治疗慢性肢体缺血患者血管生成的长期临床结果 - TACT 试验结果、预后、疗效和安全性
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [的場聖明, 他]
通讯作者: 他
共 47 条
    A molecular link between metabolic syndrome and energy metabolism in the heart
    • 批准号:
      23659423
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      MATSUBARA Hiroaki
    • 依托单位:
    Cardiac Repair of Severe Heart Failure by Human Heart- or Skeletal Muscle-Derived Multipotent Stem Cells
    • 批准号:
      17209028
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.7万
    • 财政年份:
      2005
    • 负责人:
      MATSUBARA Hiroaki
    • 依托单位:
    Angiogenic Cell Therapy by Bone Marrow-Derived Monocyte-lineage Stem Cells
    Therapeutic angiogenesis by transplantation of bone marrow stem cells
    • 批准号:
      13470152
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.24万
    • 财政年份:
      2001
    • 负责人:
      MATSUBARA Hiroaki
    • 依托单位: